The recommended dosage of ZAFIBRAL is three tablets daily, equivalent to 600 mg bezafibrate. The tablets may be taken after food.
Maintenance dosage may occasionally be reduced to two tablets daily, particularly in the treatment of hypertriglyceridaemia.
The initial response to therapy is normally rapidly apparent, although a progressive response over a number of weeks may occur. The patient's response to ZAFIBRAL should be monitored at intervals. Treatment should be terminated if an adequate response has not been achieved within 3 to 4 months.